Molinaro Caroline, Martoriati Alain, Cailliau Katia
Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
Cancers (Basel). 2021 Jul 29;13(15):3819. doi: 10.3390/cancers13153819.
Cells respond to genotoxic stress through a series of complex protein pathways called DNA damage response (DDR). These monitoring mechanisms ensure the maintenance and the transfer of a correct genome to daughter cells through a selection of DNA repair, cell cycle regulation, and programmed cell death processes. Canonical or non-canonical DDRs are highly organized and controlled to play crucial roles in genome stability and diversity. When altered or mutated, the proteins in these complex networks lead to many diseases that share common features, and to tumor formation. In recent years, technological advances have made it possible to benefit from the principles and mechanisms of DDR to target and eliminate cancer cells. These new types of treatments are adapted to the different types of tumor sensitivity and could benefit from a combination of therapies to ensure maximal efficiency.
细胞通过一系列称为DNA损伤反应(DDR)的复杂蛋白质途径对基因毒性应激做出反应。这些监测机制通过选择DNA修复、细胞周期调控和程序性细胞死亡过程,确保正确的基因组维持并传递给子细胞。经典或非经典的DDR高度有序且受到调控,在基因组稳定性和多样性中发挥关键作用。当这些复杂网络中的蛋白质发生改变或突变时,会导致许多具有共同特征的疾病以及肿瘤形成。近年来,技术进步使得受益于DDR的原理和机制来靶向和消除癌细胞成为可能。这些新型治疗方法适用于不同类型的肿瘤敏感性,并且可以受益于联合疗法以确保最大疗效。